C. Shepard, L. Finelli, and M. Alter, Global epidemiology of hepatitis C virus infection, The Lancet Infectious Diseases, vol.5, issue.9, pp.558-567, 2005.
DOI : 10.1016/S1473-3099(05)70216-4

M. Alter, Epidemiology of hepatitis C virus infection, World Journal of Gastroenterology, vol.13, issue.17, pp.2436-2441, 2007.
DOI : 10.3748/wjg.v13.i17.2436

G. Lauer and B. Walker, Hepatitis C Virus Infection, New England Journal of Medicine, vol.345, issue.1, pp.41-52, 2001.
DOI : 10.1056/NEJM200107053450107

M. Houghton and S. Abrignani, Prospects for a vaccine against the hepatitis C virus, Nature, vol.5, issue.7053, pp.961-966, 2005.
DOI : 10.1056/NEJMoa051016

M. Fried, M. Shiffman, K. Reddy, C. Smith, G. Marinos et al., Peginterferon Alfa-2a plus Ribavirin for Chronic Hepatitis C Virus Infection, New England Journal of Medicine, vol.347, issue.13, pp.975-982, 2002.
DOI : 10.1056/NEJMoa020047

J. Timm and M. Roggendorf, Sequence diversity of hepatitis C virus: Implications for immune control and therapy, World Journal of Gastroenterology, vol.13, issue.36, pp.4808-4817, 2007.
DOI : 10.3748/wjg.v13.i36.4808

S. Chevaliez and J. Pawlotsky, Interferon-based therapy of hepatitis C, Advanced Drug Delivery Reviews, vol.59, issue.12, pp.1222-1241, 2007.
DOI : 10.1016/j.addr.2007.07.002

J. Pawlotsky, S. Chevaliez, and J. Mchutchison, The Hepatitis C Virus Life Cycle as a Target for New Antiviral Therapies, Gastroenterology, vol.132, issue.5, pp.1979-1998, 2007.
DOI : 10.1053/j.gastro.2007.03.116

*. Bartenschlager, R. Frese, M. Pietschmann, and T. , Novel Insights into Hepatitis C Virus Replication and Persistence, Adv.Virus Res, vol.63, pp.71-180, 2004.
DOI : 10.1016/S0065-3527(04)63002-8

*. Moradpour, D. Penin, F. Rice, and C. , Replication of hepatitis C virus, Nature Reviews Microbiology, vol.281, issue.6, pp.453-463, 2007.
DOI : 10.1038/nrmicro1645

URL : https://hal.archives-ouvertes.fr/hal-00313684

A. Neumann, N. Lam, H. Dahari, D. Gretch, T. Wiley et al., Hepatitis C viral dynamics in vivo and the antiviral efficacy of interferon-alpha therapy, pp.282-5386, 1998.

J. Drake, B. Charlesworth, D. Charlesworth, and J. Crow, Rates of spontaneous mutation, pp.1667-1686, 1998.

P. Simmonds, Genetic diversity and evolution of hepatitis C virus - 15 years on, Journal of General Virology, vol.85, issue.11, pp.3173-3188, 2004.
DOI : 10.1099/vir.0.80401-0

Z. Keck, K. Machida, M. Lai, J. Ball, A. Patel et al., Therapeutic control of hepatitis C virus: the role of neutralizing monoclonal antibodies, Curr.Top.Microbiol.Immunol, vol.317, pp.1-38, 2008.

L. Cocquerel, C. Voisset, and J. Dubuisson, Hepatitis C virus entry: potential receptors and their biological functions, Journal of General Virology, vol.87, issue.5, pp.1075-1084, 2006.
DOI : 10.1099/vir.0.81646-0

URL : https://hal.archives-ouvertes.fr/hal-00105501

I. Tester, S. Smyk-pearson, P. Wang, A. Wertheimer, E. Yao et al., Immune evasion versus recovery after acute hepatitis C virus infection from a shared source, The Journal of Experimental Medicine, vol.11, issue.11, pp.1725-1731, 2005.
DOI : 10.1128/JVI.75.23.11392-11400.2001

A. Cox, T. Mosbruger, G. Lauer, D. Pardoll, D. Thomas et al., Comprehensive analyses of CD8+ T cell responses during longitudinal study of acute human hepatitis C, Hepatology, vol.38, issue.10, pp.104-112, 2005.
DOI : 10.1002/hep.20749

A. Cox, T. Mosbruger, Q. Mao, Z. Liu, X. Wang et al., Cellular immune selection with hepatitis C virus persistence in humans, The Journal of Experimental Medicine, vol.36, issue.11, pp.1741-1752, 2005.
DOI : 10.1016/S0022-1759(01)00535-X

L. Uebelhoer, J. Han, B. Callendret, G. Mateu, N. Shoukry et al., Stable Cytotoxic T Cell Escape Mutation in Hepatitis C Virus Is Linked to Maintenance of Viral Fitness, PLoS Pathogens, vol.10, issue.9, p.1000143, 2008.
DOI : 10.1371/journal.ppat.1000143.g007

V. Lohmann, F. Korner, J. Koch, U. Herian, L. Theilmann et al., Replication of Subgenomic Hepatitis C Virus RNAs in a Hepatoma Cell Line, Science, vol.285, issue.5424, pp.110-113, 1999.
DOI : 10.1126/science.285.5424.110

*. Bartosch, B. Dubuisson, J. Cosset, and F. , Infectious Hepatitis C Virus Pseudo-particles Containing Functional E1???E2 Envelope Protein Complexes, The Journal of Experimental Medicine, vol.72, issue.5, pp.633-642, 2003.
DOI : 10.1093/emboj/21.12.2893

URL : https://hal.archives-ouvertes.fr/inserm-00133783

*. Hsu, M. Zhang, J. Flint, M. Logvinoff, C. Cheng-mayer et al., Hepatitis C virus glycoproteins mediate pH-dependent cell entry of pseudotyped retroviral particles, Proc.Natl.Acad.Sci.U.S, pp.100-7271, 2003.
DOI : 10.1073/pnas.0832180100

H. Barth, T. Liang, and T. Baumert, Hepatitis C virus entry: Molecular biology and clinical implications, Hepatology, vol.7, issue.3, pp.527-535, 2006.
DOI : 10.1002/hep.21321

H. Von and C. Rice, Hepatitis C Virus Entry, Journal of Biological Chemistry, vol.283, issue.7, pp.3689-3693, 2008.
DOI : 10.1074/jbc.R700024200

M. Evans, H. Von, D. Tscherne, A. Syder, M. Panis et al., Claudin-1 is a hepatitis C virus coreceptor required for a late step in entry, Nature446, issue.7137, pp.801-805, 2007.

A. Haberstroh, E. Schnober, M. Zeisel, P. Carolla, H. Barth et al., Neutralizing Host Responses in Hepatitis C Virus Infection Target Viral Entry at Postbinding Steps and Membrane Fusion, Gastroenterology, vol.135, issue.5, pp.135-1719, 2008.
DOI : 10.1053/j.gastro.2008.07.018

S. Nielsen, M. Bassendine, A. Burt, C. Martin, W. Pumeechockchai et al., Association between Hepatitis C Virus and Very-Low-Density Lipoprotein (VLDL)/LDL Analyzed in Iodixanol Density Gradients, Journal of Virology, vol.80, issue.5, pp.2418-2428, 2006.
DOI : 10.1128/JVI.80.5.2418-2428.2006

B. Bartosch, G. Verney, M. Dreux, P. Donot, Y. Morice et al., An Interplay between Hypervariable Region 1 of the Hepatitis C Virus E2 Glycoprotein, the Scavenger Receptor BI, and High-Density Lipoprotein Promotes both Enhancement of Infection and Protection against Neutralizing Antibodies, Journal of Virology, vol.79, issue.13, pp.79-8217, 2005.
DOI : 10.1128/JVI.79.13.8217-8229.2005

URL : https://hal.archives-ouvertes.fr/hal-00313682

M. Dreux, T. Pietschmann, C. Granier, C. Voisset, R. -. Blum et al., High Density Lipoprotein Inhibits Hepatitis C Virus-neutralizing Antibodies by Stimulating Cell Entry via Activation of the Scavenger Receptor BI, Journal of Biological Chemistry, vol.281, issue.27
DOI : 10.1074/jbc.M602706200

URL : https://hal.archives-ouvertes.fr/hal-00313930

M. Dreux and F. Cosset, The scavenger receptor BI and its ligand, HDL: partners in crime against HCV neutralizing antibodies, Journal of Viral Hepatitis, vol.80, issue.s1, pp.68-76, 2007.
DOI : 10.1038/nature05654

M. Zeisel, G. Koutsoudakis, E. Schnober, A. Haberstroh, H. Blum et al., Scavenger receptor class B type I is a key host factor for hepatitis C virus infection required for an entry step closely linked to CD81, Hepatology, vol.279, issue.6, pp.46-1722, 2007.
DOI : 10.1002/hep.21994

URL : https://hal.archives-ouvertes.fr/inserm-00395706

E. Falkowska, F. Kajumo, E. Garcia, J. Reinus, and T. Dragic, Hepatitis C Virus Envelope Glycoprotein E2 Glycans Modulate Entry, CD81 Binding, and Neutralization, Journal of Virology, vol.81, issue.15, pp.8072-8079, 2007.
DOI : 10.1128/JVI.00459-07

F. Helle, A. Goffard, V. Morel, G. Duverlie, J. Mckeating et al., The Neutralizing Activity of Anti-Hepatitis C Virus Antibodies Is Modulated by Specific Glycans on the E2 Envelope Protein, Journal of Virology, vol.81, issue.15, pp.8101-8111, 2007.
DOI : 10.1128/JVI.00127-07

J. Timpe, Z. Stamataki, A. Jennings, K. Hu, M. Farquhar et al., Hepatitis C virus cell-cell transmission in hepatoma cells in the presence of neutralizing antibodies, Hepatology, vol.7, issue.1, pp.17-24, 2008.
DOI : 10.1002/hep.21959

X. Wei, J. Decker, S. Wang, H. Hui, J. Kappes et al., Antibody neutralization and escape by HIV-1, Nature, vol.422, issue.6929, pp.307-312, 2003.
DOI : 10.1038/nature01470

P. Kwong, M. Doyle, D. Casper, C. Cicala, S. Leavitt et al., HIV-1 evades antibody-mediated neutralization through conformational masking of receptorbinding sites, pp.420-678, 2002.

M. Law, T. Maruyama, J. Lewis, E. Giang, A. Tarr et al., Broadly neutralizing antibodies protect against hepatitis C virus quasispecies challenge, Nature Medicine, vol.78, issue.1, pp.25-27, 2008.
DOI : 10.1016/j.virol.2006.05.015

*. Bowen, D. Walker, and C. , Adaptive immune responses in acute and chronic hepatitis C virus infection, Nature, vol.38, issue.7053, pp.946-952, 2005.
DOI : 10.1128/JVI.78.3.1575-1581.2004

F. Lechner, D. Wong, P. Dunbar, R. Chapman, R. Chung et al., Analysis of Successful Immune Responses in Persons Infected with Hepatitis C Virus, The Journal of Experimental Medicine, vol.69, issue.9, pp.1499-1512, 2000.
DOI : 10.1073/pnas.92.7.2755

R. Thimme, D. Oldach, K. Chang, C. Steiger, S. Ray et al., Determinants of Viral Clearance and Persistence during Acute Hepatitis C Virus Infection, The Journal of Experimental Medicine, vol.43, issue.10, pp.1395-1406, 2001.
DOI : 10.1126/science.284.5415.825

R. Thimme, J. Bukh, H. Spangenberg, S. Wieland, J. Pemberton et al., Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease, Proc.Natl.Acad.Sci.U.S.A99(24), pp.15661-15668, 2002.
DOI : 10.1073/pnas.202608299

H. Wedemeyer, X. He, M. Nascimbeni, A. Davis, H. Greenberg et al., Impaired Effector Function of Hepatitis C Virus-Specific CD8+ T Cells in Chronic Hepatitis C Virus Infection, The Journal of Immunology, vol.169, issue.6, pp.3447-3458, 2002.
DOI : 10.4049/jimmunol.169.6.3447

A. Weiner, X. Paliard, M. Selby, A. Medina-selby, D. Coit et al., Intrahepatic Genetic Inoculation of Hepatitis C Virus RNA Confers Cross-Protective Immunity, Journal of Virology, vol.75, issue.15, pp.75-7142, 2001.
DOI : 10.1128/JVI.75.15.7142-7148.2001

S. Bassett, B. Guerra, K. Brasky, E. Miskovsky, M. Houghton et al., Protective immune response to hepatitis C virus in chimpanzees rechallenged following clearance of primary infection, Hepatology, vol.33, issue.6, pp.1479-1487, 2001.
DOI : 10.1053/jhep.2001.24371

M. Major, K. Mihalik, M. Puig, B. Rehermann, M. Nascimbeni et al., Previously Infected and Recovered Chimpanzees Exhibit Rapid Responses That Control Hepatitis C Virus Replication upon Rechallenge, Journal of Virology, vol.76, issue.13, pp.6586-6595, 2002.
DOI : 10.1128/JVI.76.13.6586-6595.2002

N. Shoukry, A. Grakoui, M. Houghton, D. Chien, J. Ghrayeb et al., T Cells Are Required for Protection from Persistent Hepatitis C Virus Infection, The Journal of Experimental Medicine, vol.2, issue.12, pp.1645-1655, 2003.
DOI : 10.1038/nri779

M. Nascimbeni, E. Mizukoshi, M. Bosmann, M. Major, K. Mihalik et al., Kinetics of CD4+ and CD8+ Memory T-Cell Responses during Hepatitis C Virus Rechallenge of Previously Recovered Chimpanzees, Journal of Virology, vol.77, issue.8, pp.4781-4793, 2003.
DOI : 10.1128/JVI.77.8.4781-4793.2003

A. Grakoui, N. Shoukry, D. Woollard, J. Han, H. Hanson et al., HCV Persistence and Immune Evasion in the Absence of Memory T Cell Help, Science, vol.302, issue.5645, pp.302-659, 2003.
DOI : 10.1126/science.1088774

R. Lanford, B. Guerra, D. Chavez, C. Bigger, K. Brasky et al., Cross-Genotype Immunity to Hepatitis C Virus, Journal of Virology, vol.78, issue.3, pp.1575-1581, 2004.
DOI : 10.1128/JVI.78.3.1575-1581.2004

J. Bukh, R. Thimme, J. Meunier, K. Faulk, H. Spangenberg et al., Previously Infected Chimpanzees Are Not Consistently Protected against Reinfection or Persistent Infection after Reexposure to the Identical Hepatitis C Virus Strain, Journal of Virology, vol.82, issue.16, pp.8183-8195, 2008.
DOI : 10.1128/JVI.00142-08

R. Thimme, V. Lohmann, and W. F. , A target on the move: Innate and adaptive immune escape strategies of hepatitis C virus, Antiviral Research, vol.69, issue.3, pp.129-141, 2006.
DOI : 10.1016/j.antiviral.2005.12.001

*. Urbani, S. Amadei, B. Fisicaro, P. Tola, D. Orlandini et al., Outcome of acute hepatitis C is related to virus-specific CD4 function and maturation of antiviral memory CD8 responses, Hepatology, vol.79, issue.1, pp.126-139, 2006.
DOI : 10.1002/hep.21242

*. Kaplan, D. Sugimoto, K. Newton, K. Valiga, M. Ikeda et al., Discordant role of CD4 T-cell response relative to neutralizing antibody and CD8 Tcell responses in acute hepatitis C, pp.132-654, 2007.

K. Chang, B. Rehermann, J. Mchutchison, C. Pasquinelli, S. Southwood et al., Immunological significance of cytotoxic T lymphocyte epitope variants in patients chronically infected by the hepatitis C virus., Journal of Clinical Investigation, vol.100, issue.9, pp.2376-2385, 1997.
DOI : 10.1172/JCI119778

A. Weiner, A. Erickson, J. Kansopon, K. Crawford, E. Muchmore et al., Persistent hepatitis C virus infection in a chimpanzee is associated with emergence of a cytotoxic T lymphocyte escape variant., Proc.Natl.Acad.Sci.U.S, pp.92-2755, 1995.
DOI : 10.1073/pnas.92.7.2755

A. Erickson, Y. Kimura, S. Igarashi, J. Eichelberger, M. Houghton et al., The Outcome of Hepatitis C Virus Infection Is Predicted by Escape Mutations in Epitopes Targeted by Cytotoxic T Lymphocytes, Immunity, vol.15, issue.6, pp.883-895, 2001.
DOI : 10.1016/S1074-7613(01)00245-X

J. Timm, G. Lauer, D. Kavanagh, I. Sheridan, A. Kim et al., CD8 Epitope Escape and Reversion in Acute HCV Infection, The Journal of Experimental Medicine, vol.67, issue.12, pp.200-1593, 2004.
DOI : 10.1128/JVI.75.12.5550-5558.2001

S. Ray, L. Fanning, X. Wang, D. Netski, E. Kenny-walsh et al., Divergent and convergent evolution after a common-source outbreak of hepatitis C virus, The Journal of Experimental Medicine, vol.73, issue.11, pp.1753-1759, 2005.
DOI : 10.1046/j.1365-2249.2002.01840.x

C. Neumann-haefelin, S. Mckiernan, S. Ward, S. Viazov, H. Spangenberg et al., Dominant influence of an HLA-B27 restricted CD8+ T cell response in mediating HCV clearance and evolution, Hepatology, vol.35, issue.3, pp.43-563, 2006.
DOI : 10.1002/hep.21049

S. Urbani, C. Boni, G. Missale, G. Elia, C. Cavallo et al., Virus-Specific CD8+ Lymphocytes Share the Same Effector-Memory Phenotype but Exhibit Functional Differences in Acute Hepatitis B and C, Journal of Virology, vol.76, issue.24, pp.12423-12434, 2002.
DOI : 10.1128/JVI.76.24.12423-12434.2002

H. Spangenberg, S. Viazov, N. Kersting, C. Neumann-haefelin, D. Mckinney et al., Intrahepatic CD8+ T-cell failure during chronic hepatitis C virus infection, Hepatology, vol.79, issue.4, pp.828-837, 2005.
DOI : 10.1002/hep.20856

K. Sugimoto, F. Ikeda, J. Stadanlick, F. Nunes, H. Alter et al., Suppression of HCV-specific T cells without differential hierarchy demonstrated ex vivo in persistent HCV infection, Hepatology, vol.38, issue.6, pp.38-1437, 2003.
DOI : 10.1053/jhep.2003.09026

R. Cabrera, Z. Tu, Y. Xu, R. Firpi, H. Rosen et al., An immunomodulatory role for CD4+CD25+ regulatory T lymphocytes in hepatitis C virus infection, Hepatology, vol.3, issue.5, pp.1062-1071, 2004.
DOI : 10.1002/hep.20454

T. Boettler, H. Spangenberg, C. Neumann-haefelin, E. Panther, S. Urbani et al., T Cells with a CD4+CD25+ Regulatory Phenotype Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Chronic Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.12, pp.7860-7867, 2005.
DOI : 10.1128/JVI.79.12.7860-7867.2005

S. Rushbrook, S. Ward, E. Unitt, S. Vowler, M. Lucas et al., Regulatory T Cells Suppress In Vitro Proliferation of Virus-Specific CD8+ T Cells during Persistent Hepatitis C Virus Infection, Journal of Virology, vol.79, issue.12, pp.7852-7859, 2005.
DOI : 10.1128/JVI.79.12.7852-7859.2005

T. Manigold, E. Shin, E. Mizukoshi, K. Mihalik, K. Murthy et al., Foxp3+CD4+CD25+ T cells control virus-specific memory T cells in chimpanzees that recovered from hepatitis C, Blood, vol.107, issue.11, pp.4424-4432, 2006.
DOI : 10.1182/blood-2005-09-3903

D. Barber, E. Wherry, D. Masopust, B. Zhu, J. Allison et al., Restoring function in exhausted CD8 T cells during chronic viral infection, Nature, vol.111, issue.7077, pp.682-687, 2006.
DOI : 10.1038/nature04444

C. Day, D. Kaufmann, P. Kiepiela, J. Brown, E. Moodley et al., PD-1 expression on HIV-specific T cells is associated with T-cell exhaustion and disease progression, Nature, vol.170, issue.7109, pp.443-350, 2006.
DOI : 10.1126/science.274.5284.94

S. Urbani, B. Amadei, D. Tola, M. Massari, S. Schivazappa et al., PD-1 expression in acute hepatitis C virus (HCV) infection is associated with HCVspecific CD8 exhaustion, J Virol80, issue.22, pp.11398-11403, 2006.

H. Radziewicz, C. Ibegbu, M. Fernandez, K. Workowski, K. Obideen et al., Liver-Infiltrating Lymphocytes in Chronic Human Hepatitis C Virus Infection Display an Exhausted Phenotype with High Levels of PD-1 and Low Levels of CD127 Expression, Journal of Virology, vol.81, issue.6, pp.81-2545, 2007.
DOI : 10.1128/JVI.02021-06

D. Bowen, N. Shoukry, A. Grakoui, M. Fuller, A. Cawthon et al., Variable Patterns of Programmed Death-1 Expression on Fully Functional Memory T Cells after Spontaneous Resolution of Hepatitis C Virus Infection, Journal of Virology, vol.82, issue.10, pp.82-5109, 2008.
DOI : 10.1128/JVI.00060-08

X. Forns, J. Bukh, and R. Purcell, The challenge of developing a vaccine against hepatitis C virus, Journal of Hepatology, vol.37, issue.5, pp.684-695, 2002.
DOI : 10.1016/S0168-8278(02)00308-2

*. Lang, K. Weiner, and D. , Immunotherapy for HCV infection: next steps, Expert Review of Vaccines, vol.7, issue.7, pp.915-923, 2008.
DOI : 10.1586/14760584.7.7.915

*. Inchauspe, G. Michel, and M. , Vaccines and immunotherapies against hepatitis B and hepatitis C viruses, Journal of Viral Hepatitis, vol.23, issue.45, pp.97-103, 2007.
DOI : 10.1002/hep.20839

M. Shiina and B. Rehermann, Hepatitis C vaccines: Inducing and challenging memory T cells, Hepatology, vol.187, issue.6, pp.1395-1398, 2006.
DOI : 10.1002/hep.21210

E. Steinmann, C. Brohm, S. Kallis, R. Bartenschlager, and T. Pietschmann, Efficient trans-Encapsidation of Hepatitis C Virus RNAs into Infectious Virus-Like Particles, Journal of Virology, vol.82, issue.14, pp.7034-7046, 2008.
DOI : 10.1128/JVI.00118-08

Q. Choo, G. Kuo, R. Ralston, A. Weiner, D. Chien et al., Vaccination of chimpanzees against infection by the hepatitis C virus., Proc.Natl.Acad.Sci.U.S.A91, pp.1294-1298, 1994.
DOI : 10.1073/pnas.91.4.1294

M. Puig, M. Major, K. Mihalik, and F. Sm, Immunization of chimpanzees with an envelope protein-based vaccine enhances specific humoral and cellular immune responses that delay hepatitis C virus infection, Vaccine, vol.22, issue.8, pp.22-991, 2004.
DOI : 10.1016/j.vaccine.2003.09.010

X. Forns, P. Payette, X. Ma, W. Satterfield, G. Eder et al., Vaccination of Chimpanzees With Plasmid DNA Encoding the Hepatitis C Virus(HCV) Envelope E2 Protein Modified the Infection After Challenge With Homologous Monoclonal HCV, Hepatology, vol.28, issue.3, pp.32-618, 2000.
DOI : 10.1053/jhep.2000.9877

J. Youn, S. Park, D. Lavillette, F. Cosset, S. Yang et al., Sustained E2 antibody response correlates with reduced peak viremia after hepatitis C virus infection in the chimpanzee, Hepatology, vol.74, issue.6, pp.1429-1436, 2005.
DOI : 10.1002/hep.20934

A. Folgori, S. Capone, L. Ruggeri, A. Meola, E. Sporeno et al., A T-cell HCV vaccine eliciting effective immunity against heterologous virus challenge in chimpanzees, Nature Medicine, vol.35, issue.2, pp.12-190, 2006.
DOI : 10.1038/nm1353

C. Kuiken, K. Yusim, L. Boykin, and R. Richardson, The Los Alamos hepatitis C sequence database, Bioinformatics, vol.21, issue.3, pp.379-384, 2005.
DOI : 10.1093/bioinformatics/bth485

T. Baumert, S. Ito, D. Wong, and T. Liang, Hepatitis C virus structural proteins assemble into viruslike particles in insect cells, J.Virol, vol.72, issue.5, pp.3827-3836, 1998.

T. Baumert, J. Vergalla, J. Satoi, M. Thomson, M. Lechmann et al., Hepatitis C virus-like particles synthesized in insect cells as a potential vaccine candidate, Gastroenterology, vol.117, issue.6, pp.1397-1407, 1999.
DOI : 10.1016/S0016-5085(99)70290-8

S. Wellnitz, B. Klumpp, H. Barth, S. Ito, E. Depla et al., Binding of Hepatitis C Virus-Like Particles Derived from Infectious Clone H77C to Defined Human Cell Lines, Journal of Virology, vol.76, issue.3, pp.1181-1193, 2002.
DOI : 10.1128/JVI.76.3.1181-1193.2002

H. Barth, C. Schafer, M. Adah, F. Zhang, R. Linhardt et al., Cellular Binding of Hepatitis C Virus Envelope Glycoprotein E2 Requires Cell Surface Heparan Sulfate, Journal of Biological Chemistry, vol.278, issue.42, pp.278-41003, 2003.
DOI : 10.1074/jbc.M302267200

H. Barth, R. Cerino, M. Arcuri, M. Hoffmann, P. Schurmann et al., Scavenger Receptor Class B Type I and Hepatitis C Virus Infection of Primary Tupaia Hepatocytes, Journal of Virology, vol.79, issue.9, pp.5774-5785, 2005.
DOI : 10.1128/JVI.79.9.5774-5785.2005

H. Barth, A. Ulsenheimer, G. Pape, H. Diepolder, M. Hoffmann et al., Uptake and presentation of hepatitis C virus-like particles by human dendritic cells, Blood, vol.105, issue.9, pp.105-3605, 2005.
DOI : 10.1182/blood-2004-05-1952

H. Barth, E. Schnober, C. Neumann-haefelin, C. Thumann, M. Zeisel et al., Scavenger Receptor Class B Is Required for Hepatitis C Virus Uptake and Cross-Presentation by Human Dendritic Cells, Journal of Virology, vol.82, issue.7, pp.82-3466, 2008.
DOI : 10.1128/JVI.02478-07

M. Lechmann, K. Murata, J. Satoi, J. Vergalla, T. Baumert et al., Hepatitis C virus???like particles induce virus-specific humoral and cellular immune responses in mice, Hepatology, vol.34, issue.2, pp.417-423, 2001.
DOI : 10.1053/jhep.2001.26523

K. Murata, M. Lechmann, M. Qiao, T. Gunji, H. Alter et al., Immunization with hepatitis C virus-like particles protects mice from recombinant hepatitis C virusvaccinia infection, Proc.Natl.Acad.Sci.U.S.A100, pp.6753-6758, 2003.

M. Qiao, K. Murata, A. Davis, S. Jeong, and T. Liang, Hepatitis C virus???like particles combined with novel adjuvant systems enhance virus-specific immune responses, Hepatology, vol.10, issue.1, pp.52-59, 2003.
DOI : 10.1053/jhep.2003.50000

G. Elmowalid, M. Qiao, S. Jeong, B. Borg, T. Baumert et al., Immunization with hepatitis C virus-like particles results in control of hepatitis C virus infection in chimpanzees, Proc.Natl.Acad.Sci.U.S, pp.104-8427, 2007.
DOI : 10.1073/pnas.0702162104

C. Rollier, G. Paranhos-baccala, E. Verschoor, B. Verstrepen, J. Drexhage et al., Vaccine-induced early control of hepatitis C virus infection in chimpanzees fails to impact on hepatic PD-1 and chronicity, Hepatology, vol.201, issue.3, pp.45-602, 2007.
DOI : 10.1002/hep.21573

A. Mellor and D. Munn, Ido expression by dendritic cells: tolerance and tryptophan catabolism, Nature Reviews Immunology, vol.467, issue.10, pp.762-774, 2004.
DOI : 10.1016/S0041-1345(00)02792-5

J. Youn, Y. Hu, N. Tricoche, W. Pfahler, M. Shata et al., Evidence for Protection against Chronic Hepatitis C Virus Infection in Chimpanzees by Immunization with Replicating Recombinant Vaccinia Virus, Journal of Virology, vol.82, issue.21, pp.10896-10905, 2008.
DOI : 10.1128/JVI.01179-08

G. Strickland, S. El-kamary, P. Klenerman, and A. Nicosia, Hepatitis C vaccine: supply and demand, The Lancet Infectious Diseases, vol.8, issue.6, pp.379-386, 2008.
DOI : 10.1016/S1473-3099(08)70126-9

J. Esteban, S. Sauleda, and J. Quer, The changing epidemiology of hepatitis C virus infection in Europe, Journal of Hepatology, vol.48, issue.1, pp.148-162, 2008.
DOI : 10.1016/j.jhep.2007.07.033

J. Blackard and S. K. Hcv, HCV/ HIV co-infection: time to re-evaluate the role of HIV in the liver?, Journal of Viral Hepatitis, vol.18, issue.5, pp.323-330, 2008.
DOI : 10.1128/JVI.01890-06

C. Feray, M. Gigou, D. Samuel, B. Ducot, P. Maisonneuve et al., Incidence of Hepatitis C in Patients Receiving Different Preparations of Hepatitis B Immunoglobulins after Liver Transplantation, Annals of Internal Medicine, vol.128, issue.10, pp.810-816, 1998.
DOI : 10.7326/0003-4819-128-10-199805150-00003

C. Logvinoff, M. Major, D. Oldach, S. Heyward, A. Talal et al., Neutralizing antibody response during acute and chronic hepatitis C virus infection, Proc.Natl.Acad.Sci.U.S.A101, pp.10149-10154, 2004.
DOI : 10.1073/pnas.0403519101

J. Meunier, R. Engle, K. Faulk, M. Zhao, B. Bartosch et al., Evidence for cross-genotype neutralization of hepatitis C virus pseudo-particles and enhancement of infectivity by apolipoprotein C1, Proc.Natl.Acad.Sci.U.S, pp.102-4560, 2005.
DOI : 10.1073/pnas.0501275102

G. Davis, Hepatitis C immune globulin to prevent HCV recurrence after liver transplantation: Chasing windmills?, Liver Transplantation, vol.80, issue.9, pp.1317-1319, 2006.
DOI : 10.1002/lt.20889

G. Leroux-roels, E. Depla, F. Hulstaert, L. Tobback, S. Dincq et al., A candidate vaccine based on the hepatitis C E1 protein: tolerability and immunogenicity in healthy volunteers, Vaccine, vol.22, issue.23-24, pp.22-23, 2004.
DOI : 10.1016/j.vaccine.2004.02.002

F. Nevens, T. Roskams, V. Van, Y. Horsmans, D. Sprengers et al., A pilot study of therapeutic vaccination with envelope protein E1 in 35 patients with chronic hepatitis C, Hepatology, vol.31, issue.5, pp.38-1289, 2003.
DOI : 10.1053/jhep.2003.50474

C. Klade, H. Wedemeyer, T. Berg, H. Hinrichsen, G. Cholewinska et al., Therapeutic Vaccination of Chronic Hepatitis C Nonresponder Patients With the Peptide Vaccine IC41, Gastroenterology, vol.134, issue.5, pp.134-1385, 2008.
DOI : 10.1053/j.gastro.2008.02.058

C. Firbas, B. Jilma, E. Tauber, V. Buerger, S. Jelovcan et al., Immunogenicity and safety of a novel therapeutic hepatitis C virus (HCV) peptide vaccine: A randomized, placebo controlled trial for dose optimization in 128 healthy subjects, Vaccine, vol.24, issue.20, pp.24-4343, 2006.
DOI : 10.1016/j.vaccine.2006.03.009

S. Yutani, A. Yamada, K. Yoshida, Y. Takao, M. Tamura et al., Phase I clinical study of a personalized peptide vaccination for patients infected with hepatitis C virus (HCV) 1b who failed to respond to interferonbased therapy, pp.25-7429, 2007.